Due to Bristol Myers Squibb’s portfolio prioritization efforts, Eisai is taking back an antibody-drug conjugate that they ...

Dianthus Therapeutics has unveiled in vitro results of its drug candidate in a pair of autoimmune disease models, supporting ...

Artiva Biotherapeutics, a clinical-stage NK cell therapy biotech, is trying again for the public markets, it revealed Friday ...

As the White House kicked off a public forum on clinical trials on Wednesday, the FDA simultaneously published a delayed ...

Pierre Fabre’s overactive bladder medication won approval in Europe on Friday as a panel of experts at the European Medicines ...

The Supreme Court on Friday overruled a longstanding legal doctrine that gives federal agencies latitude to interpret federal ...

The Centers for Medicare and Medicaid Services plans to begin testing whether outcomes-based agreements might improve access ...

A Maryland federal grand jury on Thursday indicted neuroscientist Hoau-Yan Wang, a longtime Cassava Sciences collaborator, ...

Sanofi spin-off EuroAPI provided further details on its restructuring plan, with the company cutting 550 staffers and ...

Vaxart halted work on its oral vaccine for Covid-19, and didn't even have enough money to finish 2024. Now, the US government ...

The FDA re­ject­ed Rock­et Phar­ma­ceu­ti­cals’ gene ther­a­py for leuko­cyte ad­he­sion de­fi­cien­cy-I (LAD-I), ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended Merck’s recently approved 21-valent ...